Absci Corp (ABSI)
4.935
-0.06
(-1.30%)
USD |
NASDAQ |
May 08, 16:00
4.935
0.00 (0.00%)
After-Hours: 19:33
Absci Shareholders Equity (Quarterly): 176.18M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 176.18M |
| September 30, 2023 | 196.42M |
| June 30, 2023 | 215.40M |
| March 31, 2023 | 253.96M |
| December 31, 2022 | 274.41M |
| September 30, 2022 | 292.94M |
| June 30, 2022 | 316.19M |
| Date | Value |
|---|---|
| March 31, 2022 | 340.50M |
| December 31, 2021 | 366.11M |
| September 30, 2021 | 388.01M |
| June 30, 2021 | 37.12M |
| March 31, 2021 | -98.50M |
| December 31, 2020 | -89.43M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-98.50M
Minimum
Mar 2021
388.01M
Maximum
Sep 2021
205.33M
Average
253.96M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 5.022B |
| Creative Medical Technology Holdings Inc | 10.34M |
| CytomX Therapeutics Inc | -47.45M |
| HOOKIPA Pharma Inc | 89.86M |
| Recursion Pharmaceuticals Inc | 463.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.30M |
| Total Liabilities (Quarterly) | 41.12M |
| Debt to Equity Ratio | 0.0449 |
| Current Ratio | 4.079 |
| Net Debt Paydown Yield | 0.05% |